Apple continues its healthcare expansion with its first diabetes product but faces a highly crowded market with established players

July 28, 2019 | Case Study

Apple is no stranger to healthcare. However, its foray into healthcare has so far leveraged existing consumer devices like its smartphones and smartwatches. By adding on additional software and/or hardware in newer iterations of the product like the Apple Watch Series 4 and integrating the data into the Apple Health app, it has turned these devices into personal health hubs. For the first time, however, Apple has launched a medical device, One Drop, a blood glucose monitor that integrates with all of its consumer devices. Diabetes is a trillion-dollar market that's expected to double in the next 10 years if current trends persist. This presents a lucrative market opportunity that Apple clearly does not want to miss out on.  

About Lux Research

Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.

Already a Lux Client?

Sign In

Interested in Learning More?

Contact us to learn the benefits of becoming a Lux member.

Or call us now

For North America (Boston Headquarters)
+1 (617) 502-5300

For EMEA (Amsterdam)
+31 20 280 7900

For APAC (Singapore)
+65 6592-6978